74 related articles for article (PubMed ID: 10729785)
1. HIV-1 gp41 by N-domain binds the potential receptor protein P45.
Xiao Y; Wu W; Dierich MP; Chen Y
Int Arch Allergy Immunol; 2000 Mar; 121(3):253-7. PubMed ID: 10729785
[TBL] [Abstract][Full Text] [Related]
2. The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62.
Chen YH; Xiao Y; Wu W; Yang J; Sui S; Dierich MP
AIDS; 1999 Jun; 13(9):1021-4. PubMed ID: 10397530
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.
Chen YH; Wu W; Yang J; Sui SF; Sun J; Dierich MP
Immunol Lett; 1999 Aug; 69(2):253-7. PubMed ID: 10482360
[TBL] [Abstract][Full Text] [Related]
4. HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62.
Chen YH; Xiao Y; Wu W; Wang Q; Luo G; Dierich MP
Immunobiology; 2000 Jan; 201(3-4):317-22. PubMed ID: 10776788
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.
Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
J Immunol; 1993 Dec; 151(11):6583-92. PubMed ID: 8245486
[TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner.
Ebenbichler CF; Stoiber H; Schneider R; Patsch JR; Dierich MP
J Virol; 1996 Mar; 70(3):1723-8. PubMed ID: 8627693
[TBL] [Abstract][Full Text] [Related]
7. Characterization of interaction between C-domain on HIV-1 gp41 and the putative receptor protein p62.
Yang H; Xiao Y; Lu Y; Chen YH
Immunobiology; 2001 Aug; 203(5):778-85. PubMed ID: 11563677
[TBL] [Abstract][Full Text] [Related]
8. Antigenic characterization of HIV-1 gp41 binding proteins.
Chen YH; Speth C; Wu W; Stockl G; Xiao Y; Yu T; Ke Z; Zhao Y; Dierich MP
Immunol Lett; 1998 Jun; 62(2):75-9. PubMed ID: 9698101
[TBL] [Abstract][Full Text] [Related]
9. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1.
Stoiber H; Ebenbichler C; Schneider R; Janatova J; Dierich MP
AIDS; 1995 Jan; 9(1):19-26. PubMed ID: 7893437
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.
Jiang S; Lin K; Strick N; Neurath AR
Biochem Biophys Res Commun; 1993 Sep; 195(2):533-8. PubMed ID: 8373393
[TBL] [Abstract][Full Text] [Related]
11. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity.
Ryu JR; Jin BS; Suh MJ; Yoo YS; Yoon SH; Woo ER; Yu YG
Biochem Biophys Res Commun; 1999 Nov; 265(3):625-9. PubMed ID: 10600471
[TBL] [Abstract][Full Text] [Related]
12. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
[TBL] [Abstract][Full Text] [Related]
13. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120.
Stoiber H; Ebenbichler CF; Thielens NM; Arlaud GJ; Dierich MP
Mol Immunol; 1995 Apr; 32(5):371-4. PubMed ID: 7739575
[TBL] [Abstract][Full Text] [Related]
15. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
[TBL] [Abstract][Full Text] [Related]
16. A peptide inhibitor of human immunodeficiency virus infection binds to novel human cell surface polypeptides.
Henderson LA; Qureshi MN
J Biol Chem; 1993 Jul; 268(20):15291-7. PubMed ID: 8325899
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions.
Würzner R; Gruber A; Stoiber H; Spruth M; Chen YH; Lukasser-Vogl E; Schwendinger MG; Dierich MP
J Infect Dis; 1997 Aug; 176(2):492-8. PubMed ID: 9237717
[TBL] [Abstract][Full Text] [Related]
18. Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins.
Ebenbichler CF; Röder C; Vornhagen R; Ratner L; Dierich MP
AIDS; 1993 Apr; 7(4):489-95. PubMed ID: 8507415
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.
Gustchina E; Louis JM; Bewley CA; Clore GM
J Mol Biol; 2006 Dec; 364(3):283-9. PubMed ID: 17010381
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
